Alivus Life
Drug Manufacturers - Specialty & Generic · ALIVUS
Mid CapHealthcareEarly Growth
Dr. Yasir Rawjee
Managing Director and CEO · Transformational
Company DNA
Innovation-Led
About
Alivus Life is a Mid Cap company in the Healthcare sector, listed on NSE as ALIVUS. With a market cap of ₹11K Cr and revenue of ₹2K Cr, it is currently in the Early Growth phase. Known for its Innovation-Led culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Drug manufacturing and generic focus requires a high level of R&D investment and adherence to technical excellence rather than just administrative processes. Its strategic mandate: Requires disciplined product pipeline development and regulatory navigation to establish market share in the highly competitive pharma sector.
FAQ
What kind of company is Alivus Life?
Alivus Life is a Mid Cap Healthcare company (ALIVUS) in the Early Growth phase with a market cap of ₹11K Cr. It is classified as Innovation-Led in culture.
What is Alivus Life's culture and work environment like?
Alivus Life has a Innovation-Led culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Learning Ground. Customer relationship style: B2B-Enterprise. Drug manufacturing and generic focus requires a high level of R&D investment and adherence to technical excellence rather than just administrative processes.
Who leads Alivus Life?
Alivus Life is led by Dr. Yasir Rawjee (Managing Director and CEO), a Transformational leader with 32 years of experience.
What are Alivus Life's financials?
Alivus Life reported revenue of ₹2K Cr in FY25 with a 5-year revenue CAGR of 3.9%. Operating margin: 26.7%. Market cap: ₹11K Cr.
Culture & Strategy
CultureInnovation-Led
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployeeLearning Ground
BrandTechnical-Expert
LifecycleEarly Growth
Drug manufacturing and generic focus requires a high level of R&D investment and adherence to technical excellence rather than just administrative processes.
Mandate
Requires disciplined product pipeline development and regulatory navigation to establish market share in the highly competitive pharma sector.
Requires disciplined product pipeline development and regulatory navigation to establish market share in the highly competitive pharma sector.
Financials
Revenue FY25₹2K Cr
PAT FY25₹486 Cr
Rev CAGR 5Y3.9%
OPM26.7%
NPM20.8%
ROE17.2%
ROCE21.2%
P/E21.4
Fwd P/E18.7
P/B3.8
D/E2
Mkt Cap₹11K Cr
Promoter76.1%
Institutional10.6%
Similar Culture
Could You Lead Alivus Life?
Take the Genome Benchmark →